Is PetMed Express Stock a Good Investment?
PetMed Express Investment Advice | PETS |
- Examine PetMed Express' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research PetMed Express' leadership team and their track record. Good management can help PetMed Express navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Other Specialty Retail space and any emerging trends that could impact PetMed Express' business and its evolving consumer preferences.
- Compare PetMed Express' performance and market position to its competitors. Analyze how PetMed Express is positioned in terms of product offerings, innovation, and market share.
- Check if PetMed Express pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about PetMed Express' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in PetMed Express stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if PetMed Express is a good investment.
Sell | Buy |
Hold
Market Performance | Very Weak | Details | |
Volatility | Unstable | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine PetMed Express Stock
Researching PetMed Express' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 22.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.87. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PetMed Express has Price/Earnings To Growth (PEG) ratio of 2.58. The entity last dividend was issued on the 11th of August 2023. The firm had 959692:319 split on the 4th of March 1999.
To determine if PetMed Express is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding PetMed Express' research are outlined below:
| PetMed Express generated a negative expected return over the last 90 days | |
| PetMed Express has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 281.06 M. Net Loss for the year was (7.46 M) with profit before overhead, payroll, taxes, and interest of 68.37 M. | |
| PetMed Express has a strong financial position based on the latest SEC filings | |
| About 22.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Petmed Express sees 408,500 stock purchase by Nina Capital Holdings - Investing.com |
PetMed Express uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in PetMed Express. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to PetMed Express' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 5th of February 2024 Upcoming Quarterly Report | View | |
| 27th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of May 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Earnings surprises can significantly impact PetMed Express' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises PetMed Express' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2005-10-24 | 2005-09-30 | 0.1 | 0.11 | 0.01 | 10 | ||
2004-10-25 | 2004-09-30 | 0.07 | 0.08 | 0.01 | 14 | ||
2004-05-17 | 2004-03-31 | 0.07 | 0.06 | -0.01 | 14 | ||
2015-10-19 | 2015-09-30 | 0.2 | 0.22 | 0.02 | 10 | ||
2012-05-07 | 2012-03-31 | 0.18 | 0.2 | 0.02 | 11 | ||
2008-05-12 | 2008-03-31 | 0.18 | 0.2 | 0.02 | 11 | ||
2007-01-22 | 2006-12-31 | 0.13 | 0.11 | -0.02 | 15 | ||
2006-07-24 | 2006-06-30 | 0.18 | 0.2 | 0.02 | 11 |
Know PetMed Express' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as PetMed Express is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading PetMed Express backward and forwards among themselves. PetMed Express' institutional investor refers to the entity that pools money to purchase PetMed Express' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | D. E. Shaw & Co Lp | 2024-12-31 | 172 K | Ubs Group Ag | 2024-12-31 | 150.8 K | Amvescap Plc. | 2024-12-31 | 148.8 K | Invenomic Capital Management, Lp | 2024-12-31 | 148.4 K | Ameriprise Financial Inc | 2024-12-31 | 146.4 K | Man Group Plc | 2024-12-31 | 145.8 K | Millennium Management Llc | 2024-12-31 | 144.1 K | Formidable Asset Management Llc | 2024-12-31 | 135.3 K | T. Rowe Price Associates, Inc. | 2024-12-31 | 121.7 K | Renaissance Technologies Corp | 2024-12-31 | 1.3 M | Hotchkis & Wiley Capital Management Llc | 2024-12-31 | 974.1 K |
PetMed Express' market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 87.79 M.Market Cap |
|
PetMed Express' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.05) | (0.05) | |
| Return On Capital Employed | (0.08) | (0.07) | |
| Return On Assets | (0.04) | (0.04) | |
| Return On Equity | (0.07) | (0.07) |
Determining PetMed Express' profitability involves analyzing its financial statements and using various financial metrics to determine if PetMed Express is a good buy. For example, gross profit margin measures PetMed Express' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of PetMed Express' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in PetMed Express' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of PetMed Express. Check PetMed Express' Beneish M Score to see the likelihood of PetMed Express' management manipulating its earnings.
Evaluate PetMed Express' management efficiency
Return On Tangible Assets is likely to gain to -0.05 in 2025. Return On Capital Employed is likely to gain to -0.07 in 2025. At this time, PetMed Express' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 92.1 M in 2025, whereas Net Tangible Assets are likely to drop slightly above 114.5 M in 2025. PetMed Express' management efficiency ratios could be used to measure how well PetMed Express manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 4.27 | 2.81 | |
| Tangible Book Value Per Share | 2.60 | 2.72 | |
| Enterprise Value Over EBITDA | (33.86) | (32.17) | |
| Price Book Value Ratio | 1.13 | 1.08 | |
| Enterprise Value Multiple | (33.86) | (32.17) | |
| Price Fair Value | 1.13 | 1.08 | |
| Enterprise Value | 37.4 M | 35.6 M |
Understanding the operational decisions made by PetMed Express management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.
Beta 0.787 |
Basic technical analysis of PetMed Stock
As of the 22nd of March, PetMed Express holds the Variance of 15.37, coefficient of variation of (1,241), and Risk Adjusted Performance of (0.06). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of PetMed Express, as well as the relationship between them. Please check PetMed Express market risk adjusted performance and treynor ratio to decide if PetMed Express is priced some-what accurately, providing market reflects its current price of 4.25 per share. Given that PetMed Express has information ratio of (0.07), we recommend you to check out PetMed Express's recent market performance to make sure the company can sustain itself at a future point.PetMed Express' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific PetMed Express insiders, such as employees or executives, is commonly permitted as long as it does not rely on PetMed Express' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases PetMed Express insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
PetMed Express' Outstanding Corporate Bonds
PetMed Express issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. PetMed Express uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most PetMed bonds can be classified according to their maturity, which is the date when PetMed Express has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand PetMed Express' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing PetMed Express' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.30) | |||
| Mean Deviation | 2.93 | |||
| Coefficient Of Variation | (1,241) | |||
| Standard Deviation | 3.92 | |||
| Variance | 15.37 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.03) | |||
| Treynor Ratio | (0.31) | |||
| Maximum Drawdown | 23.41 | |||
| Value At Risk | (5.47) | |||
| Potential Upside | 5.72 | |||
| Skewness | (0.37) | |||
| Kurtosis | 1.67 |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.30) | |||
| Mean Deviation | 2.93 | |||
| Coefficient Of Variation | (1,241) | |||
| Standard Deviation | 3.92 | |||
| Variance | 15.37 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.03) | |||
| Treynor Ratio | (0.31) | |||
| Maximum Drawdown | 23.41 | |||
| Value At Risk | (5.47) | |||
| Potential Upside | 5.72 | |||
| Skewness | (0.37) | |||
| Kurtosis | 1.67 |
Consider PetMed Express' intraday indicators
PetMed Express intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of PetMed Express stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
PetMed Express Corporate Filings
F4 | 19th of March 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 10th of March 2025 Other Reports | ViewVerify | |
| 14th of February 2025 Other Reports | ViewVerify | |
8K | 10th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
PetMed Stock media impact
Far too much social signal, news, headlines, and media speculation about PetMed Express that are available to investors today. That information is available publicly through PetMed media outlets and privately through word of mouth or via PetMed internal channels. However, regardless of the origin, that massive amount of PetMed data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of PetMed Express news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of PetMed Express relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to PetMed Express' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive PetMed Express alpha.
PetMed Express Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards PetMed Express can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
PetMed Express Corporate Management
| Mark Moseley | Chief Officer | Profile | |
| Carla Dodds | Chief Officer | Profile | |
| Matthew Hulett | Pres CEO | Profile | |
| Umesh Sripad | Chief Officer | Profile | |
| Christine Chambers | Treasurer Secretary | Profile |
Additional Tools for PetMed Stock Analysis
When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.